Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AdvisorShares Dorsey Wright Short ETF (NQ:DWSH)

7.165 -0.065 (-0.90%)
Official Closing Price Updated: 4:15 PM EST, Nov 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AdvisorShares Dorsey Wright Short ETF

Merck Stock Rises Upon Receipt Of $700M In Funding For Experimental Cancer Drug
Via Stocktwits
Thermo Fisher To Acquire Clario Holdings In A $9.4B Deal
Thermo Fisher expects the acquisition to be immediately accretive to its adjusted operating margin. 
Via Stocktwits
Humana Stock Rises After Insurer Reaffirms Full-Year Earnings Guidance
Via Stocktwits
Illumina Stock Surged 6% Today – Here’s Why
The company announced that its new business will focus on developing data assets, software, and artificial intelligence to drive drug development. 
Via Stocktwits
Topics Artificial Intelligence
VF Corp To Sell Dickies Brand To Bluestar Alliance For $600M
Via Stocktwits
Campbell’s Gains Wall Street Confidence With Multiple Price Target Hikes, Retail Chatter Surges
Via Stocktwits
Sarepta Just Got A Good Restructuring Deal For $700M Debt, But Stock Tumbles 7% – Here’s Why
Although the company has managed to push back the maturity of the new debt to 2030, it is also offering cash and common stock to certain investors as part of the deal. 
Via Stocktwits
This Pharma Stock Shot Up 8% Today, Gets A Price Target Hike From Wells Fargo: Here’s Why Retail Sees Opportunity
Via Stocktwits
Sarepta Draws Wall Street Ire After Third Patient Death This Year: Analyst Says ‘Deeply Concerning’ The Incident Wasn’t Reported Earlier
Via Stocktwits
This Stock Has Tumbled 50% In One Year, Gets A Price Target Cut Today – But Retail Believes $400-450 Is A Good Entry Point
Truist, however, kept a ‘Buy’ rating on the shares. 
Via Stocktwits
Why Did Sarepta Stock Jump 20% On Tuesday? Here’s What JPMorgan, Bernstein, Barclays Said About Elevidys
JPMorgan upgraded Sarepta to ‘Neutral’ from ‘Underweight’ with a $24 price target. 
Via Stocktwits
Topics Death
Regeneron’s Therapy For Blood Cancer Bags FDA Approval: REGN Stock Jumps
While Lynozyfic was granted accelerated approval based on response rate in the LINKER-MM1 trial, continued approval may depend upon verification and description of clinical benefit in a confirmatory... 
Via Stocktwits
Topics Death
5 Cheap Dividend Stocks: Which to Buy Now
Marketbeat.com provides numerous tools for investors, including the List of Cheap Dividend Stocks, a treasure trove of value-plays for income investors. 
Via MarketBeat
Topics ETFs
5 Low-Risk ETFs To Buy Amid Historic Bond Turmoil
Investors are increasingly exploring diversified strategies that help to protect their portfolios from downside risk. 
Via Talk Markets
Topics ETFs
Wall Street Tumbles On Renewed Fears: 5 ETFs Standing Tall
Though terrible trading in the stock world pushed the ETF space into deep red on the day, a few ETFs still saw strength. 
Via Talk Markets
5 ETFs That Gained Double Digits in Q2
These funds have been the quarter’s star performers and could also be winners next quarter if the current trends continue. 
Via Talk Markets
5 ETFs That Gained Double Digits In Q2
While most corners of the market were deep in the red, a few have performed well. Let's take a look at the ETFs that have been the quarter’s star performers, as they could also be winners next quarter... 
Via Talk Markets
Forget Recession Fears With These ETFs
Here are five ETFs that could provide some shelter from the crisis and benefit investors’ portfolio. 
Via Talk Markets
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.